3 managers · $1.5B totalData: SEC EDGAR 13F · 2026Q2
Manager holders · last 5 qtrsⓘ
3
2025Q2 – 2026Q2 · flat QoQ
Total position
$1.5B
Combined value across tracked managers
Net move this quarter
↓ Trimming
Weighted by holders' share change
HolderQ actionValue% of port.Style
Harris (Oakmark)Trim-5.6%$1.2B1.62%Deep value / Contrarian long-term
Patient CapitalⓘTrim-0.74%$196M6.44%Contrarian growth-value / Time arbitrage
HoskingⓘTrim-16.56%$111M3.94%Contrarian value / Global diversified
What managers sayⓘ
2026-10-09Patient Capital ManagementNeutralThe Art of Imagining: Conviction without PredictionDetail →
2026-10-05Patient Capital ManagementBearOpportunity Equity Strategy Update for 09/25/2026 – 10/02/2026Detail →
2026-09-21Patient Capital ManagementNeutralOpportunity Equity Strategy Update for 09/11/2026 – 09/18/2026Detail →
2026-09-14Patient Capital ManagementBullOpportunity Equity Strategy Update for 09/04/2026 – 09/11/2026Detail →
2026-09-08Patient Capital ManagementNeutralOpportunity Equity Strategy Update for 8/28/2026 – 9/04/2026Detail →
2026-08-24Patient Capital ManagementBearOpportunity Equity Strategy Update for 8/14/2026 – 8/21/2026Detail →
2026-07-27Patient Capital ManagementBullFinding Patience in... an Early 2000s Hip-Hop Song?Detail →
2026-07-27Patient Capital ManagementNeutralOpportunity Equity Strategy Update for 7/17/2026 – 7/24/2026Detail →
Earnings Callsⓘ
Q2 2026July 21, 2026
›
### Overall ConclusionThis quarter's results exceeded expectations, primarily driven by comprehensive growth across all five business segments. In particular, the services and markets businesses reached historic highs, propelling total revenue to its best level in a decade.
### Key DataRevenue grew 14% year-over-year to $24.8 billion, with EPS of $3.15 and ROTCE of 13% (up 430 basis points year-over-year).
### Business ProgressServices revenue increased 18%, hitting a record high, with cross-border transaction volume up 13% and deposits up 19%. Markets revenue rose 17%, including a 45% increase in equities and nearly 60% growth in Prime balances. Investment banking revenue grew 44%, with the firm serving as lead underwriter in major IPOs such as SpaceX; ECM rose 92%. Wealth management posted its ninth consecutive quarter of growth, with revenue up 13% and ROTCE improving to 14.4%. In U.S. consumer cards, the acquisition of the AA Barclays portfolio was completed, and loans grew 8%. Management emphasized that AI tools now cover nearly 90% of employees, driving product innovation and enhancing customer experience.
### Guidance and OutlookThe full-year ROTCE target of 10-11% is maintained, but management explicitly stated that if the market environment remains favorable, the firm will accelerate investment to drive medium- to long-term returns. Markets revenue is expected to decline seasonally by approximately 20% in the second half, with the efficiency ratio around 60% for the full year.
### Risk/Highlight SignalsPositive signal: Management's tone was upbeat, emphasizing that "we have entered a new growth model" and explicitly stating that "a stronger environment is not just an upside report, but an investment opportunity." Negative signal: In the consumer card business, due to increased investment, expenses are expected to outpace revenue growth over the next few quarters.